Amedisys down on U.S. antitrust review on UnitedHealth deal

Amedisys

10/08/2023 23:09

** Shares of healthcare-at-home firm Amedisys Inc  AMED.O 
down 1.5% at $91 after the bell 
    ** Amedisys in a filing on Thursday says it received a
second request seeking additional information and documentary
material on its deal with UnitedHealth Group  UNH.N  from the
U.S. Department of Justice on Aug. 4 
    ** The agency issues such a request for major deals and if
it cannot resolve all of its concerns about the likely
competitive effects of a transaction during this initial
investigation period
    ** Shares of UNH was down marginally at $502.73 in extended
trading 
    ** In June, AMED agreed to a $3.3 bln sweetened cash offer
from UNH and scrapped an all-stock deal with Option Care Health
 OPCH.O 
    ** UNH is buying AMED for $101 per share, higher than its
previous offer of $100 and above the $97.38 per share all-stock
deal from Option Care in May
    ** Up to Thursday's close, stock AMED had risen ~11% so far
this year

 (Reporting by Ananya Mariam Rajesh in Bengaluru)
 ((AnanyaMariam.Rajesh@thomsonreuters.com ; Twitter: https://twitter.com/AnanyaMariam))